Financial Year End | 31 Dec 2020 |
Quarter | 3 Qtr |
Quarterly report for the financial period ended | 30 Sep 2020 |
The figures | have not been audited |
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR
CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR
CORRESPONDING PERIOD |
||
30 Sep 2020
|
30 Sep 2019
|
30 Sep 2020
|
30 Sep 2019
|
||
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
1 | Revenue |
18,192
|
16,069
|
40,809
|
45,813
|
2 | Profit/(loss) before tax |
3,959
|
3,609
|
5,791
|
9,930
|
3 | Profit/(loss) for the period |
2,928
|
2,493
|
4,153
|
6,946
|
4 | Profit/(loss) attributable to ordinary equity holders of the parent |
2,595
|
2,239
|
3,564
|
6,241
|
5 | Basic earnings/(loss) per share (Subunit) |
0.96
|
0.83
|
1.32
|
2.31
|
6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
0.00
|
0.00
|
0.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.1700
|
0.0000
|
Remarks : |
The net assets per share attributable to ordinary equity holders of the parent as at 31 December 2019 above is not being disclosed since it is not comparable as the number of ordinary shares as at 31 December 2019 was 2,700,000 (based on number of ordinary shares in Optimax Eye Specialist Centre Sdn. Bhd.) while the number of ordinary shares as at 30 September 2020 was 270,000,000 (based on the enlarged ordinary shares in Optimax Holdings Berhad) following the completion of the Pre-IPO Exercise and IPO referred to in Note B6. |
In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Company Name | OPTIMAX HOLDINGS BERHAD |
Stock Name | OPTIMAX |
Date Announced | 26 Nov 2020 |
Category | Financial Results |
Reference Number | FRA-23112020-00079 |
Attachments